Skip to content

Treatment of T1N0 Invasive Breast Carcinoma by Local Excision Implant

The Treatment of T1N0 Invasive Breast Carcinoma by Local Excision and Interstitial Implant

Status
Completed
Phases
Phase 1Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00977275
Enrollment
45
Registered
2009-09-15
Start date
1997-06-30
Completion date
2013-05-31
Last updated
2017-04-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Keywords

early stage invasive breast cancer, Partial breast irradiation, interstitial implant

Brief summary

The purpose of this study is to evaluate radiation therapy directed to a small region of the breast in women who were recently diagnosed with early stage invasive breast cancer.

Detailed description

* When participants undergo surgery to remove the tumor (lumpectomy), it will be followed by the placement of small flexible tubes throughout the region surrounding the site of operation. These tubes will remain in place for 7-9 days following the surgery. * The first 2-3 days, the tubes will not contain radioactivity. This time is used to do all the calculations necessary for treatment and to check the findings in the breast tissue that was removed. After 2-3 days, the tubes will be filled with a radioactive wire which will remain in place for the next 5 days. During this period of time, participants will be required to remain within the hospital. At the end of these 5 days, the radioactive wires and tubes will be removed.

Interventions

RADIATIONInterstitial Implant Brachytherapy

Via tubes placed at the time of wide local excision delivered over 5 days

Sponsors

Massachusetts General Hospital
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Low risk of multifocal disease within the breast whose tumor location is favorable for brachytherapy catheter placement * Diagnosis of invasive breast carcinoma (biopsy or fine needle aspiration cytology) and be clinical stage T1N0 (primary tumor \< 2cm, clinically negative nodes) * Location of primary tumor is not immediately adjacent to the nipple of chest wall * No evidence of two or more separate tumors within the breast * All histologic types and pathologic grades of primary tumor * No extensive intraductal component (substantial intraductal carcinoma away from the primary tumor location) * No lymphatic or vascular invasion * Lymph node staging by sentinel node excision or axillary dissection confirms node negative status (If node positive, implant is used to deliver boost to tumor bed) * Assessment of final surgical margins should be predominantly negative, but a single small region of focal positivity is allowable as it is for whole breast radiation * 18 years of age or older

Exclusion criteria

* Tumor is too close to the chest wall to allow placement of catheters * Contraindications to radiation therapy are present, including a history of scleroderma, systemic lupus or other active connective tissue disease, pregnancy, or prior chest wall radiation

Design outcomes

Primary

MeasureTime frame
To determine if interstitial implant brachytherapy to radical radiation doses is feasible following wide local excision of T1N0 breast carcinoma3 years

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026